| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |